Menu
ResMed pioneers innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Its comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, the company improves quality of life, reduces the impact of chronic disease, and lowers costs for consumers and healthcare systems in more than 140 countries.
9001 Spectrum Center Blvd
San Diego, California 92123-1438
Phone: 18587462400
www.resmed.com
SAN DIEGO, Aug. 28, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, Chairman and Chief Executive Officer, and Dr. Carlos Nunez, Chief Medical Officer, will participate in a fireside chat at the Morgan Stanley 22nd Annual Global Healthcare Conference on Wednesday, September 4, 2024, beginning at approximately 10:00 a.m. (Eastern Daylight Time) at the New York Marriott Marquis in New York, NY.
The S&P 500 added 0.2% on Tuesday, Aug. 27, ahead of Nvidia''s earnings report on Wednesday and key economic data on tap for later in the week.
Investors with a lot of money to spend have taken a bullish stance on ResMed (NYSE: RMD ). And retail traders should know. We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don''t know. But when something this big happens with RMD, it often means somebody knows something is about to happen. Today, Benzinga''s options scanner spotted 9 options trades for ResMed . This isn''t normal. The overall sentiment of these big-money traders is split between 44% bullish and 44%, bearish. Out of all of the options we uncovered, there was 1 put, for a total amount of $85,960, and 8, calls, for a total amount of $387,509. What''s The Price Target? Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $170.0 to $240.0 for ResMed over the recent three months. Volume & Open Interest Development Assessing the volume and open interest is a strategic step in options trading.
Why ResMed Inc''s Stock Skyrocketed 12% in a Quarter
https://www.investing.com/news/company-news/william-blair-stays-positive-on-resmed-stock-amid-growth-outlook-93CH-3589352
https://www.investing.com/news/company-news/resmed-executive-sells-shares-worth-over-200k-93CH-3581858
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) has released an update. ResMed Inc. has announced the appointment o…
Resmed (RMD) has provided an announcement. Christopher DelOrefice has joined the board of directors at ResMed Inc., bringing his extensive financia…
